Evidence map›Paper›PMID 36552011›Full record

ArticleBiomedicines2022

The Precise Breakpoint Mapping in Paracentric Inversion 10q22.2q23.3 by Comprehensive Cytogenomic Analysis, Multicolor Banding, and Single-Copy Chromosome Sequencing.

Tatyana V Karamysheva, Tatyana A Gayner, Eugeny A Elisaphenko, Vladimir A Trifonov, Elvira G Zakirova, Konstantin E Orishchenko, Mariya A Prokhorovich, Maria E Lopatkina, Nikolay A Skryabin, Igor N Lebedev and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Tatyana V KaramyshevaInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS), 630090 Novosibirsk, Russia.ORCID 0000-0002-5140-4350
Tatyana A GaynerInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences (SB RAS), 630090 Novosibirsk, Russia.
Eugeny A ElisaphenkoInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS), 630090 Novosibirsk, Russia.
Vladimir A TrifonovInstitute of Molecular and Cellular Biology, Siberian Branch of Russian Academy of Sciences (SB RAS), 630090 Novosibirsk, Russia.ORCID 0000-0003-0454-8359
Elvira G ZakirovaInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS), 630090 Novosibirsk, Russia.
Konstantin E OrishchenkoInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS), 630090 Novosibirsk, Russia.ORCID 0000-0001-9718-9038
Mariya A ProkhorovichInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS), 630090 Novosibirsk, Russia.ORCID 0000-0002-8957-4806
Maria E LopatkinaTomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics, 634050 Tomsk, Russia.ORCID 0000-0002-7051-3472
Nikolay A SkryabinTomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics, 634050 Tomsk, Russia.
Igor N LebedevTomsk National Research Medical Center of the Russian Academy of Sciences, Research Institute of Medical Genetics, 634050 Tomsk, Russia.ORCID 0000-0002-0482-8046
Nikolay B RubtsovInstitute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS), 630090 Novosibirsk, Russia.ORCID 0000-0001-7406-8057
Russian Academy of Sciences · RUInstitute of Cytology and Genetics · RUNovosibirsk State University · RUInstitute of Chemical Biology and Fundamental Medicine · RU

Funding

the Ministry of Education and Science of Russian Federation #2019-0546 (FSUS-2020-0040)the Ministry of Science and Higher Education of the Russian Federation via IC&G SB RAS #FWNR-2022-0015the Russian Science Foundation № 21-65-00017 (https://rscf.ru/en/project/21-65-00017/)
6 · The paper itself

Abstract

Detection and precise genomic mapping of balanced chromosomal abnormalities in patients with impaired fertility or a clinical phenotype represent a challenge for current cytogenomics owing to difficulties with precise breakpoint localization in the regions enriched for DNA repeats and high genomic variation in such regions. Here, we present a comprehensive cytogenomic approach to breakpoint mapping in a rare paracentric inversion on 10q (in a patient with oligoasthenoteratozoospermia and necrozoospermia) that does not affect other phenotype traits. Multicolor banding, chromosomal microarray analysis, chromosome microdissection with reverse painting, and single-copy sequencing of the rearranged chromosome were performed to determine the length and position of the inverted region as well as to rule out a genetic imbalance at the breakpoints. As a result, a paracentric 19.251 Mbp inversion at 10q22.2q23.3 was described. The most probable location of the breakpoints was predicted using the hg38 assembly. The problems of genetic counseling associated with enrichment for repeats and high DNA variability of usual breakpoint regions were discussed. Possible approaches for cytogenomic assessment of couples with balanced chromosome rearrangements and problems like reproductive failures were considered and suggested as useful part of effective genetic counseling.

Indexed as

array-based comparative genomic hybridizationbreakpoint mappingchromosomal microdissectioninv(10)multicolor bandingoligoasthenoteratozoospermiaparacentric inversionreproductive failuresingle-copy chromosome sequencing

Identifiers

PMID36552011
PMCPMC9775520
OpenAlexW4311788527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.